Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€400.30
Target price
01.02.25
€404.41
Performance (%)
5.22%
Price
24.05.24
€421.20
Summary
This prediction is currently active. With a performance of 5.22%, the BUY prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 01.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | 2.845% | 2.845% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $390.00 to $438.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat